Novartis Ag Ceo Talks Medicinal Sales | Bloomberg Talks

Novartis AG CEO Talks Medicinal Sales | Bloomberg Talks

Bloomberg Podcasts

Novartis generated $40 billion in innovative medicine sales, says CEO

CNBC Television

Novartis CEO Vas Narasimhan on The David Rubenstein Show

David Rubenstein

Novartis ‘focusing on high-end, innovative medicines,’ CEO says

Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine

CNBC Television

Novartis CEO Narasimhan Talks Raising Outlook | Bloomberg Talks

Bloomberg Podcasts

Joe Jimenez, CEO of Novartis at Berkeley-Haas

Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

CNBC International News

Novartis CEO on Acquisitions, AI, Weight-Loss Drugs

David Rubenstein

Vasant Narasimhan Novartis CEO On Transforming Pharma Industry

James Surowiecki talks with CEO of Novartis AG Dan Vasella - Conversations - The New Yorker

Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises

CNBC Television

Novartis CEO: Confident about continued sales growth for rest of year

CNBC International News

Novartis expects 'strong momentum' going into second half, says CEO Vasant Narasimhan

CNBC Television

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company

Innovative medicines business returning to growth, Novartis CEO says

CNBC International News

Novartis Can Meet Growing Demand for Gene Therapy: CEO

Bloomberg Television

Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug

CNBC Television

"I don’t feel pressure from shareholders," says Novartis CEO Vas Narasimhan